Long term results of TAX324, a randomized phase III trial of sequential therapy with TPF versus PF in locally advanced squamous cell cancer of the head and neck

BACKGROUND: With a minimum follow up of 2 years, the TAX324 study demonstrated a significant survival benefit of induction chemotherapy (IC) with docetaxel, cisplatin and 5FU (TPF) versus cisplatin and 5fluorouracil (PF) followed by chemoradiotherapy with carboplatin delivered as sequential therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Lorch, Jochen H., Goloubeva, Olga, Haddad, Robert I., Cullen, Kevin, Sarlis, Nicholas, Tishler, Roy, Tan, Ming, Fasciano, John, Sammartino, Daniel E., Posner, Marshall R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356902/
https://ncbi.nlm.nih.gov/pubmed/21233014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(10)70279-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados